title: c-sis but not c-fos gene expression is lineage specific in human myeloid cells.
abstract: Expression of both the c-fos and c-sis protooncogenes during myeloid differentiation has been detected in cells of the monocytic lineage. Since an increase in c-fos transcripts was not detected during dimethylsulfoxide induced HL-60 granulocytic differentiation, it was suggested that within the myeloid series c-fos gene expression might be lineage specific. In the present study, we have determined whether expression of the c-fos and c-sis genes is indeed specific for the monocytic pathway or rather common to both the granulocyte and monocyte pathways. C-fos and c-sis gene expression was analyzed in freshly isolated human granulocytes and monocytes, in human HL-60 promyelocytic leukemia cells induced to differentiate along the granulocytic or monocytic pathway, in myeloblasts from five patients with the M1 or M2 subtype of acute myeloblastic leukemia (AML) and in blasts from six patients with M4 myelomonocytic leukemia. The level of c-fos mRNA was fifteen times higher in granulocytes as compared with monocytes. An increase in c-fos expression was also found in HL-60 cells differentiated along the granulocytic pathway after exposure to hypoxanthine, hexamethylene bisacetamide, and the combination of retinoic acid and dibutyryl adenosine 3'5' cyclic monophosphate. Three of 5 M1 and M2 leukemic myeloblast preparations depleted of lymphoid and monocytic cells and all six M4 leukemic cells expressed c-fos transcripts. In contrast, c-sis gene transcripts were detectable in monocytes and during drug induced monocytic differentiation of the HL-60 cells but not in granulocytes during granulocytic differentiation of the HL-60 cells or in AML samples. Thus, in the myeloid series, c-sis gene expression is lineage specific while expression of the c-fos gene is found in both lineages and may be related to metabolic pathways common to both granulocytes and monocytes.
authors.affiliation: Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Boston, MA 02115.
authors.forename: E
authors.initials: E
authors.lastname: Sariban
authors.forename: T
authors.initials: T
authors.lastname: Mitchell
authors.forename: A
authors.initials: A
authors.lastname: Rambaldi
authors.forename: D W
authors.initials: DW
authors.lastname: Kufe
mesh_terms: D000199:Actins / Q000235:genetics; D001752:Blast Crisis; D001854:Bone Marrow Cells; D002454:Cell Differentiation; D005786:Gene Expression Regulation; D006098:Granulocytes / Q000502:physiology*; D006801:Humans; D007938:Leukemia / Q000235:genetics; D009000:Monocytes / Q000502:physiology*; D010982:Platelet-Derived Growth Factor / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D020574:Proto-Oncogene Proteins c-sis; D014407:Tumor Cells, Cultured
chemical_list: D000199:Actins; D010982:Platelet-Derived Growth Factor; D011518:Proto-Oncogene Proteins; D020574:Proto-Oncogene Proteins c-sis